PUNCH CD3-OLS: a phase 3 prospective observational cohort study to evaluate the safety and efficacy of fecal microbiota, live-jslm (REBYOTA) in adults with recurrent Clostridioides difficile infection - Feuerstadt, P; Chopra, T; Knapple, W (Clin Infect Dis, 2024)